Combinatorial Chemistry: Oh What a Decade or Two Can Do

Overview

Journal Mol Divers

Date 2009 Mar 4

PMID 19255865

Citations 9

Authors

Walter H Moos

Clarence R Hurt

Guillermo A Morales

Affiliations

Soon will be listed here.

Abstract

This short commentary takes a stroll through the early days of the field of combinatorial chemistry and molecular diversity. It offers a high-level perspective on the field's beginnings--and its future--as it relates to journals, books, pioneers, and advances.

Citing Articles

An Automated Purification Workflow Coupled with Material-Sparing High-Throughput H NMR for Parallel Medicinal Chemistry.

Bellenger J, Koos M, Avery M, Bundesmann M, Ciszewski G, Khunte B ACS Med Chem Lett. 2024; 15(9):1635-1644.

PMID: 39291006 PMC: 11403749. DOI: 10.1021/acsmedchemlett.4c00245.

High-Throughput Purification in Drug Discovery: Scaling New Heights of Productivity.

Jones M, Goodyear R ACS Med Chem Lett. 2023; 14(7):916-919.

PMID: 37465307 PMC: 10351054. DOI: 10.1021/acsmedchemlett.3c00073.

Deep Eutectic Solvent (DES)-Mediated One-Pot Multicomponent Green Approach for Naphthalimide-Centered Acridine-1,8-dione Derivatives and Their Photophysical Properties.

Rather I, Alotaibi S, Alotaibi M, Altaf M, Ali R ACS Omega. 2022; 7(40):35825-35833.

PMID: 36249394 PMC: 9558244. DOI: 10.1021/acsomega.2c04026.

Mo@GAA-FeO MNPs: a highly efficient and environmentally friendly heterogeneous magnetic nanocatalyst for the synthesis of polyhydroquinoline derivatives.

Aghaei-Hashjin M, Yahyazadeh A, Abbaspour-Gilandeh E RSC Adv. 2022; 11(18):10497-10511.

PMID: 35423550 PMC: 8695836. DOI: 10.1039/d1ra00396h.

Getting the most out of PubChem for virtual screening.

Kim S Expert Opin Drug Discov. 2016; 11(9):843-55.

PMID: 27454129 PMC: 5045798. DOI: 10.1080/17460441.2016.1216967.

References

Kolb H, Finn M, Sharpless K . Click Chemistry: Diverse Chemical Function from a Few Good Reactions. Angew Chem Int Ed Engl. 2001; 40(11):2004-2021. DOI: 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5. View

Lebl M . Parallel personal comments on "classical" papers in combinatorial chemistry. J Comb Chem. 2000; 1(1):3-24. DOI: 10.1021/cc9800327. View

Veber D, Johnson S, Cheng H, Smith B, Ward K, Kopple K . Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002; 45(12):2615-23. DOI: 10.1021/jm020017n. View

Muller G . Medicinal chemistry of target family-directed masterkeys. Drug Discov Today. 2003; 8(15):681-91. DOI: 10.1016/s1359-6446(03)02781-8. View

Balakin K, Tkachenko S, Lang S, Okun I, Ivashchenko A, Savchuk N . Property-based design of GPCR-targeted library. J Chem Inf Comput Sci. 2002; 42(6):1332-42. DOI: 10.1021/ci025538y. View

Schreiber S . Target-oriented and diversity-oriented organic synthesis in drug discovery. Science. 2000; 287(5460):1964-9. DOI: 10.1126/science.287.5460.1964. View

Lam K, Salmon S, Hersh E, Hruby V, Kazmierski W, Knapp R . A new type of synthetic peptide library for identifying ligand-binding activity. Nature. 1991; 354(6348):82-4. DOI: 10.1038/354082a0. View

Nishizawa R, Nishiyama T, Hisaichi K, Matsunaga N, Minamoto C, Habashita H . Spirodiketopiperazine-based CCR5 antagonists: Lead optimization from biologically active metabolite. Bioorg Med Chem Lett. 2006; 17(3):727-31. DOI: 10.1016/j.bmcl.2006.10.084. View

Habashita H, Kokubo M, Hamano S, Hamanaka N, Toda M, Shibayama S . Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonists. J Med Chem. 2006; 49(14):4140-52. DOI: 10.1021/jm060051s. View

10.

Martin E, Blaney J, Siani M, Spellmeyer D, Wong A, Moos W . Measuring diversity: experimental design of combinatorial libraries for drug discovery. J Med Chem. 1995; 38(9):1431-6. DOI: 10.1021/jm00009a003. View

11.

. Combinatorial chemistry. Nat Biotechnol. 2001; 18 Suppl:IT50-2. View

12.

Fodor S, Read J, Pirrung M, Stryer L, Lu A, Solas D . Light-directed, spatially addressable parallel chemical synthesis. Science. 1991; 251(4995):767-73. DOI: 10.1126/science.1990438. View

13.

Studer A, Hadida S, Ferritto R, Kim S, Jeger P, Wipf P . Fluorous synthesis: a fluorous-phase strategy for improving separation efficiency in organic synthesis. Science. 1997; 275(5301):823-6. DOI: 10.1126/science.275.5301.823. View

14.

Houghten R . General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A. 1985; 82(15):5131-5. PMC: 390513. DOI: 10.1073/pnas.82.15.5131. View

15.

Lipinski C, Lombardo F, Dominy B, Feeney P . Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001; 46(1-3):3-26. DOI: 10.1016/s0169-409x(00)00129-0. View

16.

Liddle J, Allen M, Borthwick A, Brooks D, Davies D, Edwards R . The discovery of GSK221149A: a potent and selective oxytocin antagonist. Bioorg Med Chem Lett. 2007; 18(1):90-4. DOI: 10.1016/j.bmcl.2007.11.008. View

17.

Zuckermann R, Martin E, Spellmeyer D, Stauber G, Shoemaker K, Kerr J . Discovery of nanomolar ligands for 7-transmembrane G-protein-coupled receptors from a diverse N-(substituted)glycine peptoid library. J Med Chem. 1994; 37(17):2678-85. DOI: 10.1021/jm00043a007. View

18.

Hulme C, Gore V . "Multi-component reactions : emerging chemistry in drug discovery" 'from xylocain to crixivan'. Curr Med Chem. 2003; 10(1):51-80. DOI: 10.2174/0929867033368600. View

19.

Geysen H, Meloen R, Barteling S . Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A. 1984; 81(13):3998-4002. PMC: 345355. DOI: 10.1073/pnas.81.13.3998. View

20.

Lowrie J, Delisle R, Hobbs D, Diller D . The different strategies for designing GPCR and kinase targeted libraries. Comb Chem High Throughput Screen. 2004; 7(5):495-510. DOI: 10.2174/1386207043328625. View